Action Point Financial Planning’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Action Point Financial Planning's LGND Position: Q3 2026 in Review
Action Point Financial Planning sold out of Ligand Pharmaceuticals (LGND) in Q3 2026, closing a stake of 9 shares — an estimated $2.53K sold.
Action Point Financial Planning first reported a position in LGND in Q2 2026 and held it in 1 quarter. The position peaked at $2.53K in Q2 2026. 433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Action Point Financial Planning reported no remaining Ligand Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 9 Ligand Pharmaceuticals shares in Q3 2026, an estimated $2.53K.
- Action Point Financial Planning first reported a position in Ligand Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Ligand Pharmaceuticals position peaked at $2.53K in Q2 2026.
- 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.